首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Terminalanpassungseinrichtung mit Empfänger von mehreren HDLC-Kommunikationskanälen zur Bearbeitung der Netzsteuerungsrahmen.
摘要
申请公布号
DE68914831(D1)
申请公布日期
1994.05.26
申请号
DE1989614831
申请日期
1989.06.29
申请人
INTERNATIONAL BUSINESS MACHINES CORP., ARMONK, N.Y.
发明人
THERIAS, PHILIPPE, F-06200 NICE;DALMAS, PHILIPPE, F-06270 VILLENEUVE LOUBET;MICHEL, PATRICK, F-06610 LA GAUDE;LE PENNEC, JEAN-FRANCOIS, F-06100 NICE;ESTEBAN, DANIEL, F-06800 CAGNES SUR MER
分类号
H04L29/04;H04L1/00;H04L29/06;H04L29/08;(IPC1-7):H04L12/00
主分类号
H04L29/04
代理机构
代理人
主权项
地址
您可能感兴趣的专利
SOFT SHAPED TORTILLAS
USE OF SPECIFIC CARBOHYDRATE SYSTEMS DURING PREGNANCY FOR EFFECTING THE OFFSPRING
DEVICE FOR DEMOLDING PARTS
NANOPARTICULATE FORMULATION COMPRISING A TRPA1 ANTAGONIST
TRANSDERMAL APPLICATION OF PROSTAGLANDIN E1 FOR THE TREATMENT OF OCULAR ISCHEMIA
DIETARY SUPPLEMENT COMPOSITIONS WITH ENHANCED DELIVERY MATRIX, AND METHODS OF MAKING THE SAME
MEDICAL DEVICE COMPRISING COLLAGEN-VI
MULTI-LAYERED STRUCTURE FOR DRUG RESERVOIR AND DRUG ELUTING STENT INCLUDING THE SAME
Home and personal care product and method for manufacturing the same
METHOD FOR TREATING DISEASE ASSOCIATED WITH TRANSCRIPTION ACTIVATION BY NF-KB
ANTI-TROP-2 ANTIBODY-DRUG CONJUGATES AND USES THEREOF
TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS
PREPARATION USEFUL FOR, AND METHOD FOR TREATMENT OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NAIT)
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
ANTI-HER3 ANTIBODIES AND USES THEREOF
NATURALLY OCCURRING AUTOANTIBODIES AGAINST ALPHA-SYNUCLEIN THAT INHIBIT THE AGGREGATION AND CYTOTOXICITY OF ALPHA-SYNUCLEIN
OPTIMIZED ANTIBODY VARIABLE REGIONS
LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCER
METHODS FOR INHIBITING HIV-1 REPLICATION INVOLVING THE ADMINISTRATION OF AN ANTI-CCR5 RECEPTOR MONOCLONAL ANTIBODY AND SMALL MOLECULE CCR5 RECEPTOR ANTAGONIST
METHOD FOR PREDICTING THE RESPONSE TO TREATMENT WITH AN HER2-BLOCKING AGENT
